Peg-interferon alpha induces CD56bright natural killer cell mediated reduction of HBsAg in entecavir treated chronic Hepatitis B patients

被引：0

作者：

Shi, Aichao ^{[1
]}

Zhang, Xiaoping ^{[1
]}

Xiao, Fang ^{[1
]}

Yan, Weiming ^{[1
]}

Han, Meifang ^{[1
]}

Chen, Tao ^{[1
]}

Ning, Qin ^{[1
]}

机构：

[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan, Hubei, Peoples R China

来源：

HEPATOLOGY | 2017年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

912

引用

页码：487A / 487A

页数：1

共 50 条

[31] HBsAg seroclearance or seroconversion induced by peg-interferon alpha and lamivudine or adefovir combination therapy in chronic hepatitis B treatment: a meta-analysis and systematic review
Zhang, Yun
Chen, Bangtao
Wang, Lin
Chit, Junjie
Song, Shaojuan
Liu, Mingshe
Zhao, Zhongfu
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2016, 108 (05) : 263 - 270
[32] The small subset of CD56bright CD16- natural killer cells is selectively responsible for both cell proliferation and interferon-γ production upon interaction with dendritic cells
Vitale, M
Della Chiesa, M
Carlomagno, S
Romagnani, C
Thiel, A
Moretta, L
Moretta, A
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (06) : 1715 - 1722
[33] Comparative analysis and effect of GM-CSF on neutropenia in Peg-Interferon alpha-2b and ribavirin-treated chronic hepatitis C patients.
Koliouskas, D
Sidiropoulos, L
Masmanidou, M
Mandraveli, K
Lazaraki, G
Dokas, S
Ziakas, A
HEPATOLOGY, 2002, 36 (04) : 587A - 587A
[34] The effect of interferon-free DAAs combination therapy on innate immune responses (NK cell activity and frequency of CD56dim and CD56bright NK cell subset in peripheral blood) in chronic hepatitis C patients
Nakamura, Ikuo
Furuichi, Yoshihiro
Sugimoto, Katsutoshi
Kobayashi, Yoshiyuki
HEPATOLOGY, 2016, 64 : 481A - 481A
[35] SYSTEMATIC PSYCHIATRIC INTERVENTION IN CHRONIC HEPATITIS C PATIENTS TREATED BY PEG-INTERFERON A2B AND RIBAVIRIN: RANDOMIZED MULTICENTER PROSPECTIVE STUDY
Guillemard, C.
Cognard, C.
Bretagne, A. -L.
Elfadel, S.
Even, C.
Beaujard, E.
Collet, T.
Lion, L.
Toudic, J. -P
Cohen, D.
Ollivier-Hourmand, I.
Chastang, F.
Dao, T.
JOURNAL OF HEPATOLOGY, 2009, 50 : S222 - S222
[36] RELATIVE ROLES OF NATURAL-KILLER-CELL-MEDIATED AND T-CELL-MEDIATED ANTILEUKEMIA EFFECTS IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH INTERFERON-ALPHA
PAWELEC, G
DASILVA, P
MAX, H
KALBACHER, H
SCHMIDT, H
BRUSERUD, O
ZUGEL, U
BAIER, W
REHBEIN, A
POHLA, H
LEUKEMIA & LYMPHOMA, 1995, 18 (5-6) : 471 - 478
[37] Increased Proportion of the CD56bright NK Cell Subset in Patients Chronically Infected With Hepatitis C Virus (HCV) Receiving Interferon-α and Ribavirin Therapy
Lee, Silvia
Watson, Mark W.
Flexman, James P.
Cheng, Wendy
Hammond, Talia
Price, Patricia
JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (04) : 568 - 574
[38] THE BALANCE BETWEEN CD56+BRIGHT AND CD56+DlM NATURAL KILLER CELL SUBSETS IN THE LIVER OF PATIENTS WITH RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION
Yamagiwa, Satoshi
Kamimura, Hiroteru
Tsuchiya, Atsunori
Takamura, Masaaki
Matsuda, Yasunobu
Sato, Yoshinobu
Ichida, Takafumi
Aoyagi, Yutaka
HEPATOLOGY, 2008, 48 (04) : 769A - 770A
[39] Imbalance between CD56+bright and CD56+dim natural killer cell subsets in the liver of patients with recurrent hepatitis C after liver transplantation
Yamagiwa, Satoshi
Sato, Yoshinobu
Ichida, Takafumi
Setsu, Toru
Tominaga, Kentaro
Kamimura, Hiroteru
Tsuchiya, Atsunori
Takamura, Masaaki
Matsuda, Yasunobu
Aoyagi, Yutaka
BIOMEDICAL RESEARCH-TOKYO, 2014, 35 (03): : 177 - 184
[40] The effect of interferon-free Asunaprevir/Daclatasvir combination therapy on innate immune responses (NK cell activity and frequency of CD56dim and CD56bright NK cell subset in peripheral blood) in chronic hepatitis C patients
Nakamura, Ikuo
Furuichi, Yoshihiro
Sugimoto, Katsutoshi
Kobayashi, Yoshiyuki
Moriyasu, Fuminori
HEPATOLOGY, 2015, 62 : 721A - 722A

← 1 2 3 4 5 →